SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039207
Filing Date
2022-02-14
Accepted
2022-02-14 06:39:59
Documents
1
Group Members
BAIN CAPITAL LIFE SCIENCES FUND II, L.P.BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d314298dsc13ga.htm SC 13G/A 119213
  Complete submission text file 0001193125-22-039207.txt   120952
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 22624949
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A